Cleared Traditional

K802164 - 8-HYDROXYQUINOLINE, CRESOLPHTHALEIN COM.
(FDA 510(k) Clearance)

Oct 1980
Decision
32d
Days
Class 2
Risk

K802164 is an FDA 510(k) clearance for the 8-HYDROXYQUINOLINE, CRESOLPHTHALEIN COM.. This device is classified as a Cresolphthalein Complexone, Calcium (Class II - Special Controls, product code CIC).

Submitted by Panmed, Inc. (Mchenry, US). The FDA issued a Cleared decision on October 10, 1980, 32 days after receiving the submission on September 8, 1980.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1145.

Submission Details

510(k) Number K802164 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 1980
Decision Date October 10, 1980
Days to Decision 32 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary

Device Classification

Product Code CIC — Cresolphthalein Complexone, Calcium
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1145

Similar Devices — CIC Cresolphthalein Complexone, Calcium

All 98
HITACHI CLINICAL ANALYZER S TEST REAGENT CARTRIDGE CALCIUM (CA)
K130870 · Hitachi Chemical Diagnostics, Inc. · May 2013
DIMENSION RXL MAX WITH ADVIA MODULAR AUTOMATION SYSTEM (AMAS)
K083339 · Siemens Healthcare Diagnostics, Inc. · Mar 2009
ABX PENTRA 400, CALCIUM CP, CREATININE CP, PHOSPHORUS CP, AMYLASE CP, URINE CONTROL L/H
K070249 · Horiba Abx · Apr 2007
SPOTCHEM II CHEMISTRY BASIC 1 AND CHEMISTRY BASIC 2 TESTS
K053401 · Arkray, Inc. · Mar 2006
SPOTCHEM II CALCIUM, MAGNESIUM, AND BLOOD UREA NITROGEN TESTS
K050077 · Arkray, Inc. · Feb 2005
RAICHEM CALCIUM (OCPC) LIQUID REAGENT
K041009 · Hemagen Diagnostics, Inc. · Jun 2004